Meridian Co., Ltd.
OTC Bulletin Board : MRDAF

Meridian Co., Ltd.

July 19, 2007 09:00 ET

Meridian Co. Receives CE Mark Approval for its Aesthetic Laser

VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 19, 2007) - Meridian Co., Ltd. ("the Company") (OTCBB:MRDAF) today announced its European notified body has granted CE Mark approval for the Company's LAPEX Laser Body Contouring System (LAPEX BCS). This approval will allow the Company to begin marketing the LAPEX BCS in the European Union (EU) and other countries around the world that recognize the CE Mark approval.

The CE Mark certifies that the product has met EU health, safety and environmental requirements that ensure consumer and workplace safety.

To the Company's knowledge, the LAPEX BCS is the only low level laser device available that can provide total inch loss in a non-invasive manner. Meridian currently has potential distributors ready to begin an aggressive marketing and sales campaign in the UK, Germany, Spain, Austria, Switzerland, Italy, and South Africa.

Commenting on this CE Mark approval, Meridian Co. President, Mr. Myeong said, "We are excited to be able to provide this valuable service to consumers and to further develop our global presence."

More About: LAPEX BCS

The LAPEX BCS was designed to target the medical and aesthetic market, specifically to address body shaping/contouring and spot fat reduction. This non-invasive treatment is considered one of the most innovative methods to treat those stubborn areas of fat that do not respond to diet and exercise. The demand for this type of treatment is expected to grow rapidly, not only in the plastic surgery profession but in any clinical setting such as medi-spas and wellness centers.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received FDA clearance, CE Mark, Health Canada, and other international regulatory approvals. Meridian has over 1500 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers worldwide.

On Behalf of the Board of Directors, Hyeon Seong Myeong President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contact Information